Morgan Stanley’s T-REX 2X Inverse CRCL Daily Target ETF CRCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-169
Closed -$1.14K 8698
2026
Q1
$1.14K Buy
+169
New +$4.63K ﹤0.01% 7415

Other funds holding CRCD

Morgan Stanley's CRCD Position: Q2 2026 in Review

Morgan Stanley sold out of T-REX 2X Inverse CRCL Daily Target ETF (CRCD) in Q2 2026, closing a stake of 169 shares — an estimated $1.14K sold.

Morgan Stanley first reported a position in CRCD in Q1 2026 and held it in 1 quarter. The position peaked at $1.14K in Q1 2026. 12 funds tracked by Wall St. Rank hold CRCD as of Q2 2026.

  • Morgan Stanley reported no remaining T-REX 2X Inverse CRCL Daily Target ETF position as of Q2 2026 after selling out during the quarter.
  • Morgan Stanley sold 169 T-REX 2X Inverse CRCL Daily Target ETF shares in Q2 2026, an estimated $1.14K.
  • Morgan Stanley first reported a position in T-REX 2X Inverse CRCL Daily Target ETF in Q1 2026 and held it in 1 quarter.
  • Morgan Stanley's T-REX 2X Inverse CRCL Daily Target ETF position peaked at $1.14K in Q1 2026.
  • 12 funds tracked by Wall St. Rank held T-REX 2X Inverse CRCL Daily Target ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.